Paroxysmal atrial fibrillation (AF) as a complication of autologous stem cell transplant (ASCT) with higher doses of melphalan (MEL) in multiple myeloma (MM) patients.

被引:0
|
作者
Hari, P [1 ]
Thumma, S [1 ]
Bredeson, C [1 ]
Drobyski, W [1 ]
Horowitz, M [1 ]
Kovatovic, K [1 ]
Olson, L [1 ]
Johnson, VP [1 ]
Keever-Taylor, C [1 ]
Rizzo, JD [1 ]
Wade, JC [1 ]
Vesole, DH [1 ]
机构
[1] Med Coll Wisconsin, Div Neoplast Dis & Related Disorders, Milwaukee, WI 53226 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2626
引用
收藏
页码:710A / 710A
页数:1
相关论文
共 50 条
  • [1] BEAM Vs Melphalan Based Conditioning Therapy for Second Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma (MM)
    Veeraputhiran, Muthu
    Jain, Tania
    Deol, Abhinav
    Uberti, Joseph
    Kim, Seongho
    Dyson, Gregory
    Abidi, Muneer
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S112 - S113
  • [2] BEAM VS MELPHALAN BASED CONDITIONING THERAPY FOR SECOND AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) FOR MULTIPLE MYELOMA (MM)
    Veeraputhiran, M.
    Jain, T.
    Deol, A.
    Kim, S.
    Dyson, G.
    Uberti, J.
    Abidi, M.
    [J]. BONE MARROW TRANSPLANTATION, 2014, 49 : S347 - S348
  • [3] Full dose or reduced dose Melphalan (MEL) for autologous stem cell transplantation (ASCT) in multiple myeloma (MM): a single center analysis on 146 patients
    vom Hofe, F.
    Muegge, L-O
    Scholl, S.
    Hilgendorf, I
    Sayer, H.
    Yomade, O.
    Ernst, T.
    Hochhaus, A.
    von Lilienfeld-Toal, M.
    Brioli, A.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 184 - 184
  • [4] INCIDENCE AND RISK FACTORS FOR ATRIAL FIBRILLATION AND ATRIAL FLUTTER IN PATIENTS WITH MULTIPLE MYELOMA AFTER MELPHALAN CONDITIONING FOR AUTOLOGOUS STEM CELL TRANSPLANT
    Rim, Austin
    Graiser, Michael
    Mandawat, Anant
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 3276 - 3276
  • [5] Outcomes of Autologous Stem Cell Transplant (ASCT) in Patients with t (11;14) Multiple Myeloma(MM)
    Bumma, Naresh
    Zhao, Qiuhong
    Sharma, Nidhi
    Khan, Abdullah
    Chaudhry, Maria
    Benson, Don M.
    Efebera, Yvonne A.
    Devarakonda, Srinivas
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S240 - S241
  • [6] TIMING OF HIGH DOSE MELPHALAN (HDM) AND OUTCOMES FOR AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN PATIENTS WITH MULTIPLE MYELOMA (MM)
    Mahindra, A.
    Bolwell, B.
    Rybicki, L.
    Sobecks, R.
    Pohlman, B.
    Andresen, S.
    Earl, M.
    Dean, R.
    Copelan, E.
    Kalaycio, M.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 41 - 42
  • [7] Full Dose or Reduced Dose Melphalan (MEL) for Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM): A Single Center Analysis on 187 Consecutive Patients
    Brioli, Annamaria
    Felix, vom Hofe
    Muegge, Lars-Olof
    Scholl, Sebastian
    Hilgendorf, Inken
    Sayer, Herbert G.
    Yomade, Olaposi
    Ernst, Thomas
    Hochhaus, Andreas
    von Lilienfeld-Toal, Marie
    [J]. BLOOD, 2018, 132
  • [8] The influence of autologous stem cell transplant (ASCT) on survival in older adults with multiple myeloma (MM).
    Wildes, Tanya Marya
    Finney, Joseph D.
    Fiala, Mark
    Gao, Feng
    Vij, Ravi
    Stockerl-Goldstein, Keith
    Carson, Kenneth Robert
    Colditz, Graham A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] Outcomes of Autologous Stem Cell Transplant (ASCT) in African-American (AA) Patients with Multiple Myeloma (MM)
    Jain, Tania
    Diab, Maria
    Awali, Reda
    Uberti, Joseph
    Ratanatharathorn, Voravit
    Ayash, Lois Jeanne
    Deol, Abhinav
    Bhutani, Divaya
    Abidi, Muneer H.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S139 - S140
  • [10] Overcoming the Effect of Racial Disparities in Multiple Myeloma (MM) with Autologous Stem Cell Transplant (ASCT)
    Bumma, Naresh
    Zhao, Qiuhong
    Khan, Abdullah
    Chaudhry, Maria
    Sharma, Nidhi
    Rosko, Ashley
    Benson, Don M.
    Efebera, Yvonne A.
    Devarakonda, Srinivas
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S235 - S236